Trailing-twelve-month (TTM) revenue is $574.78 Million with a year-over-year growth of +10.62%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $138,743,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q4 FY2025Period ended 2025-12-31 | $143,354,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-05 |
| Q1 FY2026Period ended 2026-03-31 | $138,915,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q2 FY2026Period ended 2026-06-30 | $153,770,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $574,782,000 |
Current P/S: $1,917,036,588 market capitalization ÷ $574,782,000 TTM revenue = 3.34x.
Market capitalization source: FMP quote. Quote observed 2026-09-24T19:45:25.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $153.77M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-24T19:45:31.516Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|
| Aerospace & Defense | $70M | $78M | $75M | $81M |
| Industrial | $193M | $257M | $248M | $268M |
| Medical | $85M | $85M | $78M | $82M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20132013-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|
| Asia-Pacific | N/A | $35M | $29M | $25M | $25M |
| Europe | N/A | $130M | $151M | $146M | $161M |
| Outside United States |
$574.78M
$574.78 Million
+10.62%
vs. $519.60M a year ago (TTM)
+8.02%
5 Year compound annual growth rate
1 Year
+10.62%
3 Year
+1.00%
5 Year
+8.02%
10 Year
+9.04%
15 Year
+12.46%
20 Year
+10.34%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $554.48M | +$24.51M | +4.62% |
| 2024 | $529.97M | ($48.67M) | (8.41%) |
| 2023 | $578.63M | +$75.65M | +15.04% |
| 2022 | $502.99M | +$99.47M | +24.65% |
| 2021 | $403.52M | +$36.82M | +10.04% |
| 2020 |
TTM Growth
+10.62%
3-Year CAGR
+1.00%
5-Year CAGR
+8.02%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-24T19:45:31.516Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| Other | $24M | $25M | N/A | N/A |
|---|
| Vehicle | $130M | $133M | $103M | $97M |
|---|
| $54M |
| N/A |
| N/A |
| N/A |
| N/A |
| United States | N/A | $338M | $399M | $359M | $369M |
|---|
| $366.69M |
| ($4.39M) |
| (1.18%) |
| 2019 | $371.08M | +$60.47M | +19.47% |
| 2018 | $310.61M | +$58.60M | +23.25% |
| 2017 | $252.01M | +$6.12M | +2.49% |
| 2016 | $245.89M | +$13.46M | +5.79% |
